Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,734.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 2,792.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 2,182
  • Market Cap: £1,144.99m
  • RiskGrade: 128

Regulatory News

Interim Results 22-Feb-2024 07:00 RNS
Trading Update 15-Feb-2024 07:00 RNS
Block listing Interim Review 01-Feb-2024 16:24 RNS
Total Voting Rights 01-Feb-2024 16:21 RNS
Non-Executive Director Appointment 12-Dec-2023 07:00 RNS
Result of AGM 22-Nov-2023 13:08 RNS
AGM Trading Update 22-Nov-2023 07:00 RNS
Total Voting Rights 01-Nov-2023 16:46 RNS
Capital Markets Event 01-Nov-2023 07:00 RNS
Annual Report and Annual General Meeting 13-Oct-2023 07:00 RNS
Pos. determination-PRRS resistant pigs-Colombia 05-Oct-2023 10:19 RNS
Total Voting Rights 02-Oct-2023 11:12 RNS
Director/PDMR Shareholding 15-Sep-2023 13:07 RNS
Director/PDMR Shareholding 15-Sep-2023 10:04 RNS
Preliminary Results 07-Sep-2023 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,734.00p
Change Today -22.00p
% Change -1.25 %
52 Week High 2,792.00
52 Week Low 1,637.00
Volume 2,182
Shares Issued 66.03m
Market Cap £1,144.99m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average95.64% below the market average
96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average96.23% below the sector average
Price Trend
58.97% below the market average58.97% below the market average58.97% below the market average58.97% below the market average58.97% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Income
85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
69.65% below the market average69.65% below the market average69.65% below the market average69.65% below the market average69.65% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 19-Apr-2024

Time Volume / Share Price
08:28 34 @ 1,734.00p
08:24 5 @ 1,740.00p
08:24 28 @ 1,740.00p
08:24 134 @ 1,740.00p
08:24 51 @ 1,740.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page